Ondansetron Tablet, Orally Disintegrating
Product Images NDC 51655-913

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 51655-913). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 913 53 Master Bottle Label Approval Rev A 01 21)

Packaging label for Ondansetron Orally Disintegrating Tablets, USP 4 mg, containing 10 tablets. Label indicates prescription use only. The product is labeled by Northwind Pharmaceuticals and repackaged by Rising Health, LLC. Storage instructions specify 20°-25°C with excursions permitted to 15°-30°C. The label includes dosage directions to see the package insert and notes the unit-dose package is child-resistant. Barcode and QR code are present.*

FDA Label Image

Chemical Structure (Ondansetronod Str)

Chemical structure of Ondansetron, showing its molecular arrangement with aromatic rings and functional groups clearly depicted.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.